Beta Technologies director gets 1,071 Class A shares

Beta Technologies, Inc. director Dean Kamen received 1,071 shares of Class A common stock on January 30, 2026 at a price of $0 per share.

Rhea-AI Filing Summary

Beta Technologies, Inc. director Dean Kamen received 1,071 shares of Class A common stock on January 30, 2026 at a price of $0 per share. This brought his directly held Class A shares to 51,071. An additional 764,330 Class A shares are held indirectly by the Dean Kamen Revocable Trust.

Insider Trade Summary

Grant/Award: 1,071 shares

Grant/Award 2 txns

Insider Kamen Dean

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A common stock	1,071	$0.00	$0.00
holding	Class A common stock	--	--	--

Holdings After Transaction: Class A common stock — 51,071 shares (Direct); Class A common stock — 764,330 shares (Indirect, By the Dean Kamen Revocable Trust)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Beta Technologies (BETA) report for Dean Kamen?

Beta Technologies reported that director Dean Kamen received 1,071 Class A common shares. The shares were acquired on January 30, 2026 at a price of $0 per share, increasing his directly held Class A stake to 51,071 shares.

At what price did Dean Kamen acquire new Beta Technologies (BETA) shares?

Dean Kamen acquired 1,071 Beta Technologies Class A shares at $0 per share. The transaction occurred on January 30, 2026 and appears as an acquisition, increasing his direct holdings without any stated purchase price outlay.

How many Beta Technologies (BETA) shares does Dean Kamen own directly after this transaction?

After the January 30, 2026 transaction, Dean Kamen directly owns 51,071 Class A shares of Beta Technologies. This reflects the addition of 1,071 shares acquired at $0 per share as reported in the insider filing.

What Beta Technologies (BETA) shares are held through the Dean Kamen Revocable Trust?

The filing states that 764,330 Beta Technologies Class A shares are held indirectly through the Dean Kamen Revocable Trust. This position is reported as indirect beneficial ownership, separate from Kamen’s 51,071 directly held shares.

What is Dean Kamen’s role at Beta Technologies (BETA)?

Dean Kamen is reported as a director of Beta Technologies. The insider filing identifies his relationship to the issuer as a director, with no officer title or 10% owner status checked in the relationship section.

Were there any derivative securities reported for Dean Kamen at Beta Technologies (BETA)?

The insider report includes a table for derivative securities but shows no derivative positions or transactions for Dean Kamen. Only non-derivative Class A common stock holdings and the new 1,071-share acquisition are disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 08:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kamen Dean

(Last) (First) (Middle)

C/O BETA TECHNOLOGIES, INC.

1150 AIRPORT DRIVE

(Street)

SOUTH BURLINGTON VT 05403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BETA Technologies, Inc. [ BETA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock	01/30/2026		A		1,071	A	$0	51,071	D
Class A common stock								764,330	I	By the Dean Kamen Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian Dunkiel, as attorney-in-fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.